基于ZIF-8的Schottky异构连接,用于增强e6对MRSA的声动力学抗菌作用
Xiaoyang Xu1, Danni Wang2, Bingjie Leng1
1Central Hospital Affiliate to Shenyang Medical College, Shenyang 110024, China.
Colloids and surfaces. B, Biointerfaces
|January 9, 2026
概括
一种新型纳米复合物,e6@ZIF-8@Ag (CZ@Ag),通过改善反应性氧物种 (ROS) 的产生来增强声动力抗菌化疗 (SACT). 这种方法显示出对抗MRSA等耐药细菌的巨大潜力.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 抗菌研究 抗菌研究
背景情况:
- 声动力学抗微生物化疗 (SACT) 提供非侵入性治疗,但面临诸如低氧水平和低声敏剂稳定性等挑战.
- 开发有效的声敏剂对于在临床应用中推进SACT至关重要.
研究的目的:
- 开发一种新的Schottky异质连接声敏化剂,e6@ZIF-8@Ag (CZ@Ag),用于增强SACT.
- 研究CZ@Ag介导的SACT对抗抗甲素耐药黄金葡萄球菌 (MRSA) 的机制.
主要方法:
- 制造具有Schottky异质连接结构的CZ@Ag纳米复合材料.
- 在超声波照射下评估CZ@Ag的声敏化特性和对MRSA的抗菌功效.
- 涉及产生活性氧物种 (ROS),生物膜抑制和细胞膜完整性的机制研究.
主要成果:
- 该CZ@Ag纳米复合材料表现出高的电子孔分离和狭窄的带隙,促进ROS产量.
- CZ@Ag显著降低了对MRSA的最小抑制度,并在超声波3分钟后达到96.3%的抗菌率.
- 由CZ@Ag介导的SACT有效地抑制了生物膜的形成,损坏了细胞膜,并增加了透性.
结论:
- CZ@Ag 作为一个高效的 Schottky 异质连接声敏化剂用于 SACT.
- 这项研究为开发针对耐药病原体的先进抗菌疗法提供了一个有前途的战略.
更多相关视频
11:52Evaluation of Antimicrobial Activities of Nanoparticles and Nanostructured Surfaces In Vitro
Published on: April 21, 2023
3.9K
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
9.8K
相关概念视频
01:27Schottky Barrier Diode
924
Schottky barrier diodes are specialized semiconductor devices characterized by their unique construction. This construction involves combining a metal layer with a moderately doped n-type semiconductor material. This combination leads to the formation of a Schottky barrier, a pivotal element that defines the diode's operational characteristics. The core functionality of Schottky barrier diodes is their capacity to allow current to flow in only one direction due to their distinctive...
924
01:28Antimicrobial Effectiveness
897
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
897